These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11594527)

  • 21. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
    Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow transplantation in Taiwan: low incidence of acute GVHD in patients with hematologic malignancies and severe aplastic anemia.
    Chen PM; Tzeng CH; Fan FS; Hsieh RK; Wei CH
    Bone Marrow Transplant; 1994 Jun; 13(6):709-11. PubMed ID: 7920299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation.
    Baron F; Sadzot B; Wang F; Beguin Y
    Bone Marrow Transplant; 1998 Jul; 22(2):197-200. PubMed ID: 9707030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A woman complicated with immune thrombocytopenic purpura, subclinical Graves disease and peripheral neuropathy 5 years after allogeneic bone marrow transplantation].
    Ishida H; Shin-Nakai N; Imamura T; Yokoi K; Yoshihara T; Fujii N; Tsunamoto K; Hibi S; Morimoto A; Imashuku S
    Rinsho Ketsueki; 2005 Oct; 46(10):1123-8. PubMed ID: 16440775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-mesenteric artery steroid administration relieved severe refractory gastro-intestinal graft-vs.-host disease in an allogeneic bone marrow transplantation patient.
    Sato T; Sakamaki S; Nagaoka Y; Kuribayashi K; Nagamachi Y; Morii K; Honma H; Kogawa K; Kato J; Niitsu Y
    Am J Hematol; 1997 Dec; 56(4):277-80. PubMed ID: 9395192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia.
    DeZern AE; Brodsky RA
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):629-642. PubMed ID: 30047416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective engraftment of the granulocyte compartment after allogeneic bone marrow transplantation in a patient with severe aplastic anemia.
    Barriga FJ; Legues ME; Bertin P
    J Pediatr Hematol Oncol; 1996 May; 18(2):216-7. PubMed ID: 8846143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.
    First LR; Smith BR; Lipton J; Nathan DG; Parkman R; Rappeport JM
    Blood; 1985 Feb; 65(2):368-74. PubMed ID: 3881142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatopulmonary syndrome after allogeneic bone marrow transplantation.
    Griese M; Bender-Götze C
    Bone Marrow Transplant; 1999 Dec; 24(11):1249-52. PubMed ID: 10642817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
    Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
    Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus.
    Takahata M; Hashino S; Izumiyama K; Chiba K; Suzuki S; Asaka M
    Bone Marrow Transplant; 2001 Oct; 28(7):713-5. PubMed ID: 11704797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of aplastic anemia.
    Loughran TP; Storb R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):559-75. PubMed ID: 2193014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center.
    Abdelkefi A; Ben Othman T; Ladeb S; Torjman L; Hsaïri M; Ben Abdeladhim A
    Hematol J; 2003; 4(3):208-13. PubMed ID: 12764353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
    Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
    J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.